MedTrace Logo

Radiogenomic and Prognosis Analysis in Glioma

NCT04122521 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2020-02-07

No results posted yet for this study

Summary

This study aims to evaluate whether MRI can be used to predict genomics and prognosis in glioma. Given the profound prognostic significance of genetic mutations seen in glioma, there have been increasing attempts to correlate imaging characteristics with genetic, mutational and expression patterns. To be able to predict genomics and prognosis based on imaging alone will prove useful in patients with involvement of glioma in delicate areas of the brain and better reflect tumor and molecular heterogeneity.

Conditions

Interventions

DIAGNOSTIC_TEST

MRI

MRI

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Ho Sung Kim, MD PhD · Asan Medical Center

  • Ji Eun Park, MD PhD · Asan Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-12
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04122521 on ClinicalTrials.gov